These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 3137012
1. [Pharmacokinetics and pharmacodynamics of protirelin (TRH) in man]. Duntas L, Keck FS, Loos U, Pfeiffer EF. Dtsch Med Wochenschr; 1988 Sep 02; 113(35):1354-7. PubMed ID: 3137012 [Abstract] [Full Text] [Related]
2. Thyrotropin-releasing hormone: pharmacokinetic and pharmacodynamic properties in chronic renal failure. Duntas L, Wolf CF, Keck FS, Rosenthal J. Clin Nephrol; 1992 Oct 02; 38(4):214-8. PubMed ID: 1424308 [Abstract] [Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of TRH during pregnancy. Bajoria R, Oteng-Ntim E, Peek MJ, Fisk NM. Obstet Gynecol; 1997 Aug 02; 90(2):176-82. PubMed ID: 9241288 [Abstract] [Full Text] [Related]
4. Metabolism and excretion of exogenous thyrotropin-releasing hormone in humans. Bassiri RM, Utiger RD. J Clin Invest; 1973 Jul 02; 52(7):1616-9. PubMed ID: 4198107 [Abstract] [Full Text] [Related]
5. Effect of pyridostigmine on the thyroid-stimulating hormone response to thyrotropin-releasing hormone in abstinent alcoholics. Coiro V, Vescovi PP. Alcohol Clin Exp Res; 1997 Oct 02; 21(7):1308-11. PubMed ID: 9347094 [Abstract] [Full Text] [Related]
6. Plasma levels of exogenous thyrotropin-releasing hormone (TRH) in normal subjects: relationship to endocrine and behavioral effects. Loosen PT, Youngblood W, Dew B. Pharmacopsychiatry; 1985 Nov 02; 18(6):325-9. PubMed ID: 3937164 [Abstract] [Full Text] [Related]
7. Use of a pharmacokinetic model to characterize the thyrotropin (TSH) and prolactin (PRL) response to thyrotropin-releasing hormone (THR) in man. Perret G, Valensi P, Hugues JN, Vassy R, Uzzan B. Methods Find Exp Clin Pharmacol; 1988 Jun 02; 10(6):387-91. PubMed ID: 3137402 [Abstract] [Full Text] [Related]
8. Serum concentrations of thyroxine, 3,5,3'-triiodothyronine, thyrotropin, and prolactin in dogs before and after thyrotropin-releasing hormone administration. Kaufman J, Olson PN, Reimers TJ, Allen TA, Soderberg SF, Nett TM, Wheeler SL, Wingfield WE. Am J Vet Res; 1985 Feb 02; 46(2):486-92. PubMed ID: 3922262 [Abstract] [Full Text] [Related]
9. Comparative study of intravenous, nasal, oral and buccal TRH administration among healthy subjects. Schurr W, Knoll B, Ziegler R, Anders R, Merkle HP. J Endocrinol Invest; 1985 Feb 02; 8(1):41-4. PubMed ID: 3921595 [Abstract] [Full Text] [Related]
10. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone. Foley TP, Jacobs LS, Hoffman W, Daughaday WH, Blizzard RM. J Clin Invest; 1972 Aug 02; 51(8):2143-50. PubMed ID: 4626583 [Abstract] [Full Text] [Related]
11. Serum thyrotropin responses to synthetic thyrotropin-releasing hormone in normal children and hypopituitary patients. A new test to distinguish primary releasing hormone deficiency from primary pituitary hormone deficiency. Foley TP, Owings J, Hayford JT, Blizzard RM. J Clin Invest; 1972 Feb 02; 51(2):431-7. PubMed ID: 4621544 [Abstract] [Full Text] [Related]
12. [Intranasal TRH for the stimulation of hypophyseal and thyroid reserves. Preliminary report]. Ryff-de-Lèche AS, Staub JJ, Paul S, Polc B, Girard J. Schweiz Med Wochenschr; 1985 Mar 09; 115(10):342-3. PubMed ID: 3920752 [Abstract] [Full Text] [Related]
13. Melatonin response to TRH in prepubertal and pubertal healthy subjects. Guzzaloni G, Grugni G, Tonelli E, Ardizzi A, Caló G, Moro D, Mazzilli G, Morabito F. Horm Metab Res; 1993 Aug 09; 25(8):434-7. PubMed ID: 8225189 [Abstract] [Full Text] [Related]
14. Thyrotropin-releasing hormone time-dependently influences thyrotropin microheterogeneity--an in vivo study in euthyroidism. Schaaf L, Theodoropoulou M, Gregori A, Leiprecht A, Trojan J, Klostermeier J, Stalla GK. J Endocrinol; 2000 Jul 09; 166(1):137-43. PubMed ID: 10856892 [Abstract] [Full Text] [Related]
15. Influence of central dopaminergic activity on thyrotropin responsiveness to thyrotropin-releasing hormone in normal and thyrotoxic subjects. Röjdmark S. Horm Metab Res; 1986 Jun 09; 18(6):407-10. PubMed ID: 3089893 [Abstract] [Full Text] [Related]
16. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response. Snyder PJ, Utiger RD. J Clin Invest; 1973 Sep 09; 52(9):2305-12. PubMed ID: 4199417 [Abstract] [Full Text] [Related]
17. Absorption of thyrotropin-releasing hormone after oral administration of TRH tartrate monohydrate in the rat, dog and human. Yokohama S, Yamashita K, Toguchi H, Takeuchi J, Kitamori N. J Pharmacobiodyn; 1984 Feb 09; 7(2):101-11. PubMed ID: 6427443 [Abstract] [Full Text] [Related]
18. Change in serum thyroid-stimulating hormone concentration in response to administration of thyrotropin-releasing hormone to healthy dogs, hypothyroid dogs, and euthyroid dogs with concurrent disease. Scott-Moncrieff JC, Nelson RW. J Am Vet Med Assoc; 1998 Nov 15; 213(10):1435-8. PubMed ID: 9828939 [Abstract] [Full Text] [Related]
19. Thyrotropin-releasing hormone is not required for thyrotropin secretion in the perinatal rat. Theodoropoulos T, Braverman LE, Vagenakis AG. J Clin Invest; 1979 Apr 15; 63(4):588-94. PubMed ID: 108290 [Abstract] [Full Text] [Related]
20. Effect of 1.25 (OH)2 vitamin D3 (calcitriol) on TRH-induced thyrotropin secretion in man. Zofková I, Bednár J. Exp Clin Endocrinol; 1988 Mar 15; 91(1):7-12. PubMed ID: 3131152 [Abstract] [Full Text] [Related] Page: [Next] [New Search]